Cargando...
Novel clinical trial designs for the development of new antiretroviral agents
The resounding success of combination antiretroviral efficacy for both treatment-naïve and -experienced patients – with 70% – 90% viral suppression rates in recent studies–has made registration trials for new agents challenging. With the inevitable specter of drug resistance, new agents must have a...
Gardado en:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3343181/ https://ncbi.nlm.nih.gov/pubmed/22301412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e3283519371 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|